Milanese startup active in MedTech for the development of innovative technologies dedicated to the treatment of ocular diseases
MGShell has raised €1.1M across 1 funding round from 5 investors, most recently a round in Apr 2025. Based in Milan, Italy; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-04-30 | Other | €1.1M |
| Bios Line Holding,Capital Cell,Club degli Investitori through Simon Fiduciaria,Dr. Andrea Giani,Italian Angels for Biotech |
| View deal → |
